Attached files
| file | filename |
|---|---|
| EX-10.6 - ALPEX COLLABORATION AND LICENSE AGREEMENT - Citius Pharmaceuticals, Inc. | ctxr_ex106.htm |
| EX-10.5 - THREE-PARTY AGREEMENT - Citius Pharmaceuticals, Inc. | ctxr_ex105.htm |
| EX-10.11 - SUPRENZA QUALITY AGREEMENT - Citius Pharmaceuticals, Inc. | ctxr_ex1011.htm |
| S-1/A - FORM S-1/A - Citius Pharmaceuticals, Inc. | ctxr_s1a.htm |
| EX-10.7 - CONSULTANT SERVICE AGREEMENT - Citius Pharmaceuticals, Inc. | ctxr_ex107.htm |
| EX-10.9 - AGREEMENT OR PROPOSAL - Citius Pharmaceuticals, Inc. | ctxr_ex109.htm |
| EX-10.8 - CITIUS LICENSE AGREEMENT - Citius Pharmaceuticals, Inc. | ctxr_ex108.htm |
| EX-10.10 - SUPRENZA QUALITY AGREEMENT - Citius Pharmaceuticals, Inc. | ctxr_ex1010.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment No. 1 to the Registration Statement on Form S-1 of Citius Pharmaceuticals, Inc. of our report dated December 29, 2014, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our Firm under the caption "Experts" in such Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
October 16, 2015